Is ZTS Worth Buying in 2026?

ZOETIS INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether ZOETIS INC. (ZTS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 50 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-6.09% over 10 days); weak 1-year return of -50.7%; 3-month momentum negative (-35.5%). Currently 53.0% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

ZTS is trading below its 200-day MA ($112.10) — a key warning sign the longer-term trend is under pressure. An RSI of 49.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -50.7% compares to +16.5% for SPY (trailed the market by 67.2%). The current 53.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $4,931 today
vs. S&P 500 (SPY) — same period trailed market by 67.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($112.10)
Above 50-day MA ($77.08)
RSI(14) neutral zone (30–70) — currently 49.7
Positive return (-50.7%)
!Within 10% of period high (−53.0%)
Period Range $75.35
$71.47 $160.48
RSI (14) 49.7
0 · OversoldOverbought · 100

Key Metrics

Price$75.35
Period Return-50.7%
Period High$160.48
Period Low$71.47
Drawdown−53.0%
MA-50$77.08
MA-200$112.10
RSI (14)49.7
Avg Volume (30d)6.6M
vs. SPYtrailed by 67.2%
Return Rank#850 of 999

Trade ZTS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers